
Ebenezer O. Sackey
Examiner (ID: 17838)
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1613, 1201, 1626, 1624, 1621 |
| Total Applications | 2086 |
| Issued Applications | 1598 |
| Pending Applications | 91 |
| Abandoned Applications | 399 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7034262
[patent_doc_number] => 20050032772
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-10
[patent_title] => 'Compounds useful as reversible inhibitors of cysteine proteases'
[patent_app_type] => utility
[patent_app_number] => 10/937636
[patent_app_country] => US
[patent_app_date] => 2004-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60264
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20050032772.pdf
[firstpage_image] =>[orig_patent_app_number] => 10937636
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/937636 | Compounds useful as reversible inhibitors of cysteine proteases | Sep 8, 2004 | Issued |
Array
(
[id] => 432359
[patent_doc_number] => 07265132
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-09-04
[patent_title] => 'Compounds useful as reversible inhibitors of cysteine proteases'
[patent_app_type] => utility
[patent_app_number] => 10/937533
[patent_app_country] => US
[patent_app_date] => 2004-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60330
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/265/07265132.pdf
[firstpage_image] =>[orig_patent_app_number] => 10937533
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/937533 | Compounds useful as reversible inhibitors of cysteine proteases | Sep 8, 2004 | Issued |
Array
(
[id] => 7127993
[patent_doc_number] => 20050059737
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-17
[patent_title] => 'Process of hydrocyanation of unsaturated carboxylic acid derivatives'
[patent_app_type] => utility
[patent_app_number] => 10/935819
[patent_app_country] => US
[patent_app_date] => 2004-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6378
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20050059737.pdf
[firstpage_image] =>[orig_patent_app_number] => 10935819
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/935819 | Process of hydrocyanation of unsaturated carboxylic acid derivatives | Sep 7, 2004 | Issued |
Array
(
[id] => 7216337
[patent_doc_number] => 20050054631
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-10
[patent_title] => 'Substituted indoles as inhibitors of poly (ADP-ribose) polymerase (PARP)'
[patent_app_type] => utility
[patent_app_number] => 10/933098
[patent_app_country] => US
[patent_app_date] => 2004-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30821
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20050054631.pdf
[firstpage_image] =>[orig_patent_app_number] => 10933098
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/933098 | Substituted indoles as inhibitors of poly (ADP-ribose) polymerase (PARP) | Aug 31, 2004 | Issued |
Array
(
[id] => 278161
[patent_doc_number] => 07557237
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-07-07
[patent_title] => 'Process for the synthesis of 3-(3-fluoro-4-hydroxyphenyl)-7-hydroxynaphthonitrile'
[patent_app_type] => utility
[patent_app_number] => 10/933184
[patent_app_country] => US
[patent_app_date] => 2004-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2901
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/557/07557237.pdf
[firstpage_image] =>[orig_patent_app_number] => 10933184
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/933184 | Process for the synthesis of 3-(3-fluoro-4-hydroxyphenyl)-7-hydroxynaphthonitrile | Aug 31, 2004 | Issued |
Array
(
[id] => 7083916
[patent_doc_number] => 20050049296
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-03
[patent_title] => 'Process for the synthesis of cPLA2 inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/930534
[patent_app_country] => US
[patent_app_date] => 2004-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6126
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20050049296.pdf
[firstpage_image] =>[orig_patent_app_number] => 10930534
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/930534 | Process for the synthesis of cPLA2 inhibitors | Aug 30, 2004 | Issued |
Array
(
[id] => 5689213
[patent_doc_number] => 20060287528
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-21
[patent_title] => 'Novel crystalline forms of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor'
[patent_app_type] => utility
[patent_app_number] => 10/569566
[patent_app_country] => US
[patent_app_date] => 2004-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 8324
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20060287528.pdf
[firstpage_image] =>[orig_patent_app_number] => 10569566
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/569566 | Novel crystalline forms of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor | Aug 26, 2004 | Abandoned |
Array
(
[id] => 7117250
[patent_doc_number] => 20050070551
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-31
[patent_title] => 'Novel crystalline forms of conazoles and methods of making and using the same'
[patent_app_type] => utility
[patent_app_number] => 10/926842
[patent_app_country] => US
[patent_app_date] => 2004-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 34976
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0070/20050070551.pdf
[firstpage_image] =>[orig_patent_app_number] => 10926842
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/926842 | Crystalline forms of conazoles and methods of making and using the same | Aug 25, 2004 | Issued |
Array
(
[id] => 7051308
[patent_doc_number] => 20050187195
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-25
[patent_title] => 'Inhibition of intestinal apical membrane Na/phosphate co-transportation in humans'
[patent_app_type] => utility
[patent_app_number] => 10/926841
[patent_app_country] => US
[patent_app_date] => 2004-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 19353
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0187/20050187195.pdf
[firstpage_image] =>[orig_patent_app_number] => 10926841
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/926841 | Inhibition of intestinal apical membrane Na/phosphate co-transportation in humans | Aug 25, 2004 | Abandoned |
Array
(
[id] => 644770
[patent_doc_number] => 07118763
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-10-10
[patent_title] => 'Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles'
[patent_app_type] => utility
[patent_app_number] => 10/920422
[patent_app_country] => US
[patent_app_date] => 2004-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9981
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/118/07118763.pdf
[firstpage_image] =>[orig_patent_app_number] => 10920422
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/920422 | Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles | Aug 17, 2004 | Issued |
Array
(
[id] => 7105318
[patent_doc_number] => 20050107396
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-19
[patent_title] => 'Stable crystalline form of bifeprunox mesylate (7-[4-([1,1\'-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)'
[patent_app_type] => utility
[patent_app_number] => 10/920386
[patent_app_country] => US
[patent_app_date] => 2004-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 5645
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0107/20050107396.pdf
[firstpage_image] =>[orig_patent_app_number] => 10920386
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/920386 | Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate) | Aug 17, 2004 | Issued |
Array
(
[id] => 5591480
[patent_doc_number] => 20060040932
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-23
[patent_title] => 'Stable crystalline form of bifeprunox mesylate (7-[4-([1,1\'-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)'
[patent_app_type] => utility
[patent_app_number] => 10/920361
[patent_app_country] => US
[patent_app_date] => 2004-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 6307
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20060040932.pdf
[firstpage_image] =>[orig_patent_app_number] => 10920361
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/920361 | Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate) | Aug 17, 2004 | Issued |
Array
(
[id] => 7258312
[patent_doc_number] => 20040260112
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-23
[patent_title] => 'Method of producing nitrile compounds'
[patent_app_type] => new
[patent_app_number] => 10/489838
[patent_app_country] => US
[patent_app_date] => 2004-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5709
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0260/20040260112.pdf
[firstpage_image] =>[orig_patent_app_number] => 10489838
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/489838 | Method of producing nitrile compounds | Aug 17, 2004 | Abandoned |
Array
(
[id] => 565461
[patent_doc_number] => 07462361
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-12-09
[patent_title] => 'N,N-dihalogenated amino acids and derivatives'
[patent_app_type] => utility
[patent_app_number] => 10/920636
[patent_app_country] => US
[patent_app_date] => 2004-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15782
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/462/07462361.pdf
[firstpage_image] =>[orig_patent_app_number] => 10920636
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/920636 | N,N-dihalogenated amino acids and derivatives | Aug 16, 2004 | Issued |
Array
(
[id] => 7169824
[patent_doc_number] => 20050202507
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Diazaphosphacycles'
[patent_app_type] => utility
[patent_app_number] => 10/914048
[patent_app_country] => US
[patent_app_date] => 2004-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 30114
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20050202507.pdf
[firstpage_image] =>[orig_patent_app_number] => 10914048
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/914048 | Diazaphosphacycles | Aug 5, 2004 | Issued |
Array
(
[id] => 7127928
[patent_doc_number] => 20050059672
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-17
[patent_title] => 'Novel farnesyl protein transferase inhibitors as antitumor agents'
[patent_app_type] => utility
[patent_app_number] => 10/911340
[patent_app_country] => US
[patent_app_date] => 2004-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33517
[patent_no_of_claims] => 120
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20050059672.pdf
[firstpage_image] =>[orig_patent_app_number] => 10911340
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/911340 | Farnesyl protein transferase inhibitors as antitumor agents | Aug 3, 2004 | Issued |
Array
(
[id] => 4530565
[patent_doc_number] => 07923558
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-04-12
[patent_title] => 'Method for obtaining pure tetrahydrocannabinol'
[patent_app_type] => utility
[patent_app_number] => 11/571864
[patent_app_country] => US
[patent_app_date] => 2004-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4491
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/923/07923558.pdf
[firstpage_image] =>[orig_patent_app_number] => 11571864
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/571864 | Method for obtaining pure tetrahydrocannabinol | Jul 18, 2004 | Issued |
Array
(
[id] => 7123136
[patent_doc_number] => 20050014965
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-20
[patent_title] => 'Method of separating metallic catalyst constituents from reaction mixtures'
[patent_app_type] => utility
[patent_app_number] => 10/891678
[patent_app_country] => US
[patent_app_date] => 2004-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5128
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20050014965.pdf
[firstpage_image] =>[orig_patent_app_number] => 10891678
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/891678 | Method of separating metallic catalyst constituents from reaction mixtures | Jul 14, 2004 | Abandoned |
Array
(
[id] => 7436198
[patent_doc_number] => 20040266855
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-30
[patent_title] => '3-(4,5,6,7-tetrahydroindol-2-ylmethylidiene)-2-indolinone derivatives as kinase inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/889050
[patent_app_country] => US
[patent_app_date] => 2004-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17543
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0266/20040266855.pdf
[firstpage_image] =>[orig_patent_app_number] => 10889050
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/889050 | 3-(4,5,6,7-tetrahydroindol-2-ylmethylidiene)-2-indolinone derivatives as kinase inhibitors | Jul 12, 2004 | Abandoned |
Array
(
[id] => 7434779
[patent_doc_number] => 20040266735
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-30
[patent_title] => 'Bisphosphonate derivatives, their preparations and uses'
[patent_app_type] => new
[patent_app_number] => 10/887895
[patent_app_country] => US
[patent_app_date] => 2004-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10363
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0266/20040266735.pdf
[firstpage_image] =>[orig_patent_app_number] => 10887895
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/887895 | Bisphosphonate derivatives, their preparations and uses | Jul 11, 2004 | Issued |